Related Experiment Video
Updated: Jul 14, 2026

Quantification, Viability Assessment, and Visualization Strategies for Acinetobacter Biofilms
Published on: August 4, 2023
Management of antimicrobial-resistant Acinetobacter in hospitals
1Laboratory of Healthcare Associated Infection, Centre for Infections, Health Protection Agency, London. tyrone.pitt@hpa.org.uk
Abstract:
This article examines the management of outbreaks of multi-drug resistant (MDR) Acinetobocter in hospitals. It briefly describes the organism and its properties and then discusses its role in disease and the risk to hospital patients, routes of transmission and patient reservoirs, mechanisms of drug resistance and susceptibility to antimicrobial agents, and measures for controlling outbreaks in hospitals. The success of these measures is illustrated by a detailed review of the control of an outbreak of MDR Acinetobacter boumannii infection in an intensive care unit in a London teaching hospital without closure of the ward or isolation of the patients.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Acute Pyelonephritis II: Diagnostic Studies and Management
Clinical Significance of Antibiotic Resistance
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Development of Antibiotic Resistance
